Retinal imaging technology company, Optos, has announced a dual milestone achievement of over 25,000 devices installed worldwide, and a collection of 2,500 clinical and peer-reviewed studies spanning 235 disease states.
Optos CEO, Mr Robert Kennedy, said the milestone demonstrates the more than 30 years of positive impact the company has had on the standard of retinal imaging technology and advancement of patient care.
“This remarkable double milestone reflects the unwavering commitment that Optos has had to innovation and excellence in providing the best and clinically relevant technology available, since our inception,” he said.
“The ongoing growth and recognition of the robust body of clinical research efforts underscores the dedication of our team to continue improving patient outcomes and driving development in ophthalmic care.”
He adds: “We extend our sincerest gratitude to our customers for their continued trust and support. Their feedback and partnership are invaluable as we strive to make retinal imaging more patient-friendly and accessible while empowering clinicians to deliver exceptional care.”
The company is said to offer the only single capture, 200 degree, ultra-widefield retinal imaging technology, and is said to continue to define the standard for comprehensive imaging beyond traditional constraints, crucial for diagnosing and managing a wide range of ocular conditions that otherwise may go undetected and undiagnosed.
Optos has expanded its technology offering with a total of nine imaging modalities available across all device platforms, including the recent addition of optomap colour rgb, natural colour and optomap blue fundus autofluorescence imaging modalities. Additionally, the combined imaging devices integrate ultra-widefield retinal imaging with optomap-guided OCT, providing clinicians with comprehensive insights into retinal health.
Optos technology is said to seamlessly integrates into a variety of healthcare settings from telehealth to retina.
“With continued prioritisation for eyecare providers on device ease of use and productivity, Optos technology streamlines workflow and enhances practice efficiency without compromising quality,” the company said.
“The commitment to patient and user-friendly solutions continues to drive modernisation and excellence in ophthalmic imaging, ultimately improving patient outcomes and enhancing practice efficiency worldwide.”
More reading
How these Australian ophthalmologists maximise Optos ultra-widefield retinal imaging
Optos hosting multiple training sessions at O=MEGA23
